ChunYang Cao

Find an error

Name: 曹春阳; ChunYang Cao
Organization: Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences , China
Department: State Key Laboratory of Bio-organic and Natural Product Chemistry
Title: Researcher/Professor(PhD)

TOPICS

Co-reporter:Yanting Wang;Shanshan Liu;Pengfei Yao;Yi Yu;Yan Zhang;Wenxian Lan;Chunxi Wang;Jiuping Ding;Wen Liu
Acta Crystallographica Section F 2015 Volume 71( Issue 8) pp:1033-1037
Publication Date(Web):
DOI:10.1107/S2053230X15011085

Nosiheptide is a member of the thiopeptide family of antibiotics which demonstrates potent activities against various bacterial pathogens. The formation of its C-terminal amide is catalysed by NosA in an unusual strategy for maturating certain thiopeptides by processing precursor peptides featuring a serine extension. Here, a recombinant C-terminally truncated selenomethionine-derivatized NosA1–111 variant from Streptomyces actuosus consisting of residues 1–111, named SeMet NosA1–111, was crystallized using the sitting-drop vapour-diffusion method. Diffraction data were collected to 2.40 Å resolution using synchrotron radiation. The crystals belonged to the primitive cubic space group P4132, with unit-cell parameters a = b = c = 143.3 Å. Assuming the presence of three molecules in the asymmetric unit, the calculated Matthews coefficient was 3.94 Å3 Da−1 and the corresponding solvent content was 40.3%.

Co-reporter:Yan Zhang;Huirong Yang;Xue Guo;Naiyan Rong;Yujiao Song;Youwei Xu
Protein & Cell 2014 Volume 5( Issue 11) pp:837-850
Publication Date(Web):2014 November
DOI:10.1007/s13238-014-0078-4
KDM5B is a histone H3K4me2/3 demethylase. The PHD1 domain of KDM5B is critical for demethylation, but the mechanism underlying the action of this domain is unclear. In this paper, we observed that PHD1KDM5B interacts with unmethylated H3K4me0. Our NMR structure of PHD1KDM5B in complex with H3K4me0 revealed that the binding mode is slightly different from that of other reported PHD fingers. The disruption of this interaction by double mutations on the residues in the interface (L325A/D328A) decreases the H3K4me2/3 demethylation activity of KDM5B in cells by approximately 50% and increases the transcriptional repression of tumor suppressor genes by approximately twofold. These findings imply that PHD1KDM5B may help maintain KDM5B at target genes to mediate the demethylation activities of KDM5B.
Co-reporter:Wei Hu, Chengkun Wang, Jingdan Liang, Tianlong Zhang, Zhongpei Hu, Zhijun Wang, Wenxian Lan, Fang Li, Houming Wu, Jianping Ding, Geng Wu, Zixin Deng and Chunyang Cao
Cell Research 2012 22(7) pp:1203-1206
Publication Date(Web):April 24, 2012
DOI:10.1038/cr.2012.66
DNA phosphorothioate (PT) modification, originally developed as an artificial tool to stabilize oligodeoxynucleotides against nuclease degradation1, was recently found to be incorporated with sulfur into DNA backbone as a novel physiological variation by the five-gene dnd cluster (dndA-dndE) products in a sequence- and stereo-specific manner2. This PT modification causes the DNA degradation (Dnd) phenotype and is widespread and quantized in bacterial genomes, working as a part of a restriction modification system3,4,5. This modification can be specifically cleaved in vitro by type IV restriction endonuclease6. DndA works as a cysteine desulfurase and assembles DndC as a 4Fe-4S cluster protein7. DndC possesses ATP pyrophosphatase activity8,9 and is predicted to have 3′-phosphoadenosine-5′-phosphosulfate (PAPS) reductase activity, whereas DndB has homology to a group of transcriptional regulators10,11. DndD, known as SpfD in Pseudomonas fluorescens Pf0-1, has ATPase activity possibly related to DNA structure alteration or nicking during PT incorporation5,12. Sequence identity (46%) and similarity (61%) to phosphoribosylaminoimidazole carboxylase (NCAIR synthetase) from Anabaena variabilis11 suggest that DndE could be a NCAIR synthase analogue13. However, DndE may also act as a sulfotransferase due to a specific PAPS binding sequence AAVGK-TLLIHLHR contained in the C-terminus of DndE from Streptomyces lividans (DndEstrep)10. Therefore, the exact function of DndE remains unknown.To address this, we over-expressed two DndE proteins from Escherichia Coli B7A (DndEB7A-full) and Salmonella enterica (DndESalm-full), respectively (Supplementary information, Data S1), both having isoelectric point values close to 9.5. Sequence alignment indicates that they have high similarity except for several residues in their C-termini (Figure 1A). The sequence-selectivity of PT modification in both strains is a d(GPSA) or a d(GPST) dinucleotide with an RP PT bond5. DndEB7A-full is unstable, so we used its C-terminus-truncated form (aa 1-110, DndEB7A-N110) for crystallization. The aggregation states of DndE proteins were determined by dynamic light scattering (DLS) assay (Supplementary information, Data S1), indicating the formation of tetramers at the concentration of 200 μM. Two-dimensional NMR 1H-15N HSQC spectra on 15N-labeled DndEB7A-N110 suggest that the DndEB7A-N110 fragment in Tris buffer is more homogeneous (Supplementary information, Figure S1). The structure was determined using the single-wavelength anomalous dispersion technique, and refined to 2.5 Å resolution with an Rfree factor of 24.2% and an R factor of 20.1% (Supplementary information, Table S1).The DndEB7A-N110 structure reveals a tetramer conformer (Figure 1B), consistent with the results from DLS assay. The tetramer adopts a quadrate fold, resembling a four-leaf clover of 62 Å in both length and width and 32 Å in height. It contains two kinds of dimers (A-E and A-M) with different stability resulted from different numbers of H-bonds in the dimer interface (Figure 1C and 1D). Two clefts (~60° and ~90°) are formed by the dimers (Figure 1E and 1F). Electrostatic surface analysis indicates that the cleft-containing side is more hydrophobic than its opposite side (Figure 1G and 1H). The K20 side-chain in each monomer extends into the tetramer center, forming hydrogen bonds with G24 and/or G21 in the next monomer, producing a large positively charged hole (Figure 1B-1D and 1G). The four monomer structures are almost identical and can be superimposed with an root-mean-square deviation of 0.33 Å over 59 backbone Cα atoms in the secondary structural region. Each monomer comprises five helices: H1 (aa 10-22), H2 (aa 27-39), H3 (aa 62-66), H4 (aa 70-77) and H5 (aa 86-102) (Figure 1A). Together with the H2 helix, a long flexible loop (aa 42-60) between the H2 and H3 helices encloses the H5 helix, where the residues R49, D50, S51 and K52 are not observable in some monomers.Dali search indicates that DndEB7A-N110 is a novel DNA-binding protein (Supplementary information, Figure S2). Thus, we performed DndEB7A-N110 binding studies using different DNA substrates in vitro, including dsDNA with or without a specific sequence (5′-GAAC-3′) for PT modification as found in E. coli B7A and Salmonella (specific dsDNA and random dsDNA in Figure 1). Since DndD is an ATPase with putative DNA-nicking actitvity5,12, we assumed that, before PT modification, DndD might hydrolyze the P-O bond between the G-A bases in PT modification sequence. Thus, two nicked dsDNA species were also tested (in one sequence, nicking is located between G-A bases in a specific sequence for PT modification, named as nicked SdsDNA; in the other sequence, nicking is designed between T-C bases in a random sequence, denoted as nicked RdsDNA, as shown in Figure 1), as well as a sequence-specific single-stranded DNA (ssDNA in Figure 1). Among different DNA substrates, DndESalm-full has the strongest binding affinity to nicked dsDNA (for both nicked SdsDNA and nicked RdsDNA, KD ~20 μM), indicating that DndE might be a nicked dsDNA binding protein (Figure 1I), and that the specific –GAAC–sequence might not be relevant for nicked DNA binding. DndEB7A-N110 has a higher binding affinity to nicked SdsDNA (KD ~30 μM) than that to nicked RdsDNA (KD ~60 μM), specific dsDNA (KD ~90 μM), random dsDNA (KD ~146.5 μM), and specific ssDNA (binding is non-detectable) (Figure 1J, Supplementary information, Table S2), suggesting that DndEB7A-N110 also slightly prefers to bind with nicked dsDNA. Among the mutants where positively charged residues in the DndEB7A-N110 surface including K17, K18, K20, K53, K87 and K91 are replaced by alanine, the K20A and K18A mutants showed significant decreases in binding affinities to specific dsDNA (K20A, KD ~690 μM; K18A, non-detectable). All these variants showed much weaker (K87A, KD 323 μM, decreased by 10-fold) or non-detectable binding to nicked SdsDNA (Figure 1K), further supporting that all these positively charged residues might be important for interaction with nicked dsDNA.In addition, we measured the interaction of DndEB7A-N110 with PAPS, ATP or ADP using the isothermal titration calorimetry assay (Supplementary information, Figure S3). In contrast with the early prediction10,11,13, DndEB7A-N110 showed no binding affinities to any of them (Supplementary information, Figure S3), consistent with the fact that the DndEB7A-N110 structure includes neither a 5′-PSB motif nor a 3′-PB motif for PAPS and PAP binding14, nor a glycine-rich P loop for ATP or ADP phosphate binding as seen in the NCAIR synthetase15,16.Taken together, the crystal structure of DndEB7A-N110 reveals that DndE is neither a sulfotransferase nor a NCAIR synthase analogue, but a possible nicked dsDNA binding protein with a previously unrecognized fold. Thus, DNA nicking (probably by DndD5,12) and nicked DNA binding by DndE might be essential for DNA PT modification.This work was supported by National Basic Research Program of China (2009CB918600 and 2011CB966300), National Natural Science Foundation of China (20872169, 20905074 and 20921091), National New Drug Design Program from Ministry of Health of China (2011ZX09506), and Pujiang Talents Awards from Science and Technology Commission of Shanghai Municipality (08PJ14117). We thank Prof Jianhua He at the beamline BL17U at SSRF (China) for assistance in data collection.(Supplementary information is linked to the online version of the paper on the Cell Research website.)
DL-Selenomethionine
Nosiheptide
1-Propanone,2,2-difluoro-1-(4-methoxyphenyl)-3-phenyl-3-(phenylamino)-
1-Propanone, 2,2-difluoro-3-hydroxy-1,3-diphenyl-